2021 annual financial data
Intellia Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -680.82%.
Operating income was -267,850,000 USD and net income was -259,718,000 USD.
Operating cash flow was -225,030,000 USD.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,053,000 USD
- Operating income
- -267,850,000 USD
- Net income
- -259,718,000 USD
- Operating cash flow
- -225,030,000 USD